“Retrospective evaluation of clinical outcome after chemotherapy for lymphoma in 15 equids (1991-2017)” was the title of a recent open-access article published in Journal of Veterinary Internal Medicine. It was authored by Daniela Luethy, Angela E. Frimberger, Daniela Bedenice, Barbara S. Byrne, Erin S. Groover, Rachel B. Gardner, Trisha Lewis, Valerie S. MacDonald, Lauren Proctor-Brown, Joy E. Tomlinson, Kenneth M. Rassnick and Amy L. Johnson.
Background
“Prognosis associated with lymphoma in horses is poorly characterized, and treatment is often palliative. Long-term outcome after chemotherapy for horses with lymphoma is not well documented.”
Conclusions and Clinical Importance
“Chemotherapy can be used successfully for treatment of horses with lymphoma. Adverse effects, most commonly mild, occurred in approximately two-thirds of treated horses.”
To read or download the complete article click here.
![[Aggregator] Downloaded image for imported item #20006](https://s3.amazonaws.com/wp-s3-equimanagement.com/wp-content/uploads/2026/05/29132751/EDCC-Unbranded-7-scaled-1-768x512.jpeg)
![[Aggregator] Downloaded image for imported item #20008](https://s3.amazonaws.com/wp-s3-equimanagement.com/wp-content/uploads/2026/05/29132757/EDCC-Unbranded-15-scaled-1-768x511.jpeg)
![[Aggregator] Downloaded image for imported item #19998](https://s3.amazonaws.com/wp-s3-equimanagement.com/wp-content/uploads/2026/05/29122748/EDCC-Unbranded-5-scaled-1-768x512.jpeg)